Literature DB >> 11880381

A role for p53 in maintaining and establishing the quiescence growth arrest in human cells.

Koji Itahana1, Goberdhan P Dimri, Eiji Hara, Yoko Itahana, Ying Zou, Pierre-Yves Desprez, Judith Campisi.   

Abstract

The p53 tumor suppressor protein induces transient growth arrest or apoptosis in response to genotoxic stress and mediates the irreversible growth arrest of cellular senescence. We present evidence here that p53 also contributes to the reversible, growth factor-dependent arrest of quiescence (G(0)). Microinjection of expression vectors encoding either MDM2 or a pRb-binding mutant of SV40 T antigen, both of which abrogate p53 function, stimulated quiescent normal human fibroblasts to initiate DNA synthesis and were 40-70% as effective as wild-type T antigen. Electrophoretic mobility shift and p53 transactivation assays showed that p53 activity was higher in quiescent and senescent cells compared with proliferating cells. As proliferating cells entered G(0) after growth factor withdrawal, the p53 mRNA level increased, followed by transient accumulation of the protein. Shortly thereafter, the expression (mRNA and protein) of p21, a p53 target gene and effector of cell cycle arrest, increased. Finally, stable expression of the HPV16 E6 oncogene or dominant negative p53 peptide, GSE-22, both of which inhibit p53 function, delayed entry into quiescence following growth factor withdrawal. Our data indicate that p53 is activated during both quiescence and senescence. They further suggest that p53 activity contributes, albeit not exclusively, to the quiescent growth arrest.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11880381     DOI: 10.1074/jbc.M201028200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1.

Authors:  Koji Itahana; Ying Zou; Yoko Itahana; Jose-Luis Martinez; Christian Beausejour; Jacqueline J L Jacobs; Maarten Van Lohuizen; Vimla Band; Judith Campisi; Goberdhan P Dimri
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

2.  Modulating the behaviors of mesenchymal stem cells via the combination of high-frequency vibratory stimulations and fibrous scaffolds.

Authors:  Zhixiang Tong; Randall L Duncan; Xinqiao Jia
Journal:  Tissue Eng Part A       Date:  2013-04-25       Impact factor: 3.845

Review 3.  Modelling mammalian cellular quiescence.

Authors:  Guang Yao
Journal:  Interface Focus       Date:  2014-06-06       Impact factor: 3.906

4.  Pan-Cancer Survey of Tumor Mass Dormancy and Underlying Mutational Processes.

Authors:  Anna Julia Wiecek; Daniel Hadar Jacobson; Wojciech Lason; Maria Secrier
Journal:  Front Cell Dev Biol       Date:  2021-07-09

Review 5.  p53: twenty five years understanding the mechanism of genome protection.

Authors:  M Gomez-Lazaro; F J Fernandez-Gomez; J Jordán
Journal:  J Physiol Biochem       Date:  2004-12       Impact factor: 4.158

6.  Autophagy drives fibroblast senescence through MTORC2 regulation.

Authors:  Monique Bernard; Bing Yang; Francis Migneault; Julie Turgeon; Mélanie Dieudé; Marc-Alexandre Olivier; Guillaume B Cardin; Mostafa El-Diwany; Katy Underwood; Francis Rodier; Marie-Josée Hébert
Journal:  Autophagy       Date:  2020-01-13       Impact factor: 16.016

7.  Controlling the fibroblastic differentiation of mesenchymal stem cells via the combination of fibrous scaffolds and connective tissue growth factor.

Authors:  Zhixiang Tong; Shilpa Sant; Ali Khademhosseini; Xinqiao Jia
Journal:  Tissue Eng Part A       Date:  2011-08-02       Impact factor: 3.845

8.  DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion.

Authors:  Francis Rodier; Denise P Muñoz; Robert Teachenor; Victoria Chu; Oanh Le; Dipa Bhaumik; Jean-Philippe Coppé; Eric Campeau; Christian M Beauséjour; Sahn-Ho Kim; Albert R Davalos; Judith Campisi
Journal:  J Cell Sci       Date:  2010-11-30       Impact factor: 5.285

9.  Inhibition of HDM2 and activation of p53 by ribosomal protein L23.

Authors:  Aiwen Jin; Koji Itahana; Kevin O'Keefe; Yanping Zhang
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

10.  miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma.

Authors:  Andrea L Kasinski; Frank J Slack
Journal:  Cancer Res       Date:  2012-09-10       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.